Posts Tagged ‘clinical trial’
Novel 5-minute workout improves blood pressure, may boost brain function
Could working out five minutes a day, without lifting a single weight or jogging a single step, reduce your heart attack risk, help you think more clearly and boost your sports performance? …
Read Full ArticleNew glioblastoma vaccine shows promising results in phase Ib clinical trial
Glioblastoma is the most aggressive type of primary brain cancer, one with a prognosis of 11-15 months with standard treatment. …
Read Full ArticleSurgery using ultrasound energy found to treat high blood pressure
A one-off operation that targets the nerves connected to the kidney has been found to maintain reduced blood pressure in hypertension patients for at least six months, …
Read Full ArticleDrug combination may become new standard treatment for advanced kidney cancer
A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, …
Read Full ArticleNew ‘Trojan horse’ cancer treatment shows early promise in multiple tumor types
A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumor cells has shown promise in patients with six different cancer types. …
Read Full ArticleInjection improves vision in a form of childhood blindness
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine …
Read Full ArticleSickle cell anemia treatment safely lowers disease burden in African children
A daily hydroxyurea pill may finally bring some relief for young children living with the painful and deadly blood disease sickle cell anemia (SCA) in resource-challenged sub-Saharan Africa …
Read Full ArticleGlobal trial shows CAR T-cell therapy can lead to durable remissions in non-Hodgkin’s lymphoma
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® …
Read Full Article91 percent response rate for venetoclax against newly diagnosed AML in older adults
Clinical trial results show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with AML. …
Read Full ArticleResearchers find promise in new treatment for peanut allergy
Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested …
Read Full Article